SHPCX (SHPCX) Stock Price & Analysis
SHPCX (SHPCX) fell 2.88% to USD 15.19 as of September 9, 2026 at 13:43 UTC, according to Nexqual real-time market data.
SHPCX last closed at USD 15.64; the session ranged USD 15.19–15.19 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 12.78–15.84 (NAS). Source: Nexqual, September 9, 2026 at 13:43 UTC.
Key Statistics (as of September 9, 2026 at 13:43 UTC)
| Price | USD 15.19 |
|---|---|
| Change | ▼ 2.88% (down) |
| Previous Close | USD 15.64 |
| Open | USD 15.19 |
| Day Range | USD 15.19 – 15.19 |
| 52-Week Range | USD 12.78 – 15.84 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (SHPCX)
Nexqual's technical model rates SHPCX "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of September 9, 2026 at 13:43 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 46.78 (neutral) |
| vs SMA50 | Above (USD 15.13) |
| MACD | 0.13 (positive) |
Financial Health Score (SHPCX)
Nexqual rates SHPCX's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 13:43 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHPAX | Saratoga Advantage Tr Health & | USD 23.28 | ▼ 2.88% |
| SBHIX | Saratoga Advantage Trust: Healt | USD 28.36 | ▼ 2.91% |
| RYCFX | Rydex Biotechnology Fund - C Cl | USD 53.9 | ▼ 2.02% |
| RYOAX | Rydex Series Fds, Biotechnology | USD 72.81 | ▼ 2.01% |
| LOGSX | Live Oak Health Sciences Fund | USD 25.99 | ▼ 2.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 13:43 UTC. This page is informational and not investment advice.